A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis

被引：0
|
作者：
Jacqueline E. Paramarta
Maureen C. Turina
Troy Noordenbos
Tanja F. Heijda
Iris C. Blijdorp
Nataliya Yeremenko
Dominique Baeten
机构：
[1] Academic Medical Center/University of Amsterdam,Department of Clinical Immunology and Rheumatology
[2] Academic Medical Center/University of Amsterdam,Laboratory of Experimental Immunology
来源：
Journal of Translational Medicine | / 14卷
关键词：
Spondyloarthritis; Nilotinib; Tyrosine kinase inhibitor; Randomized controlled trial; Mast cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A PROOF-OF-CONCEPT STUDY OF A MAGNETORHEOLOGICAL MICROPUMP
    Cesmeci, Sevki
    Hassan, Rubayet
    Thompson, Mark
    PROCEEDINGS OF ASME 2022 INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, IMECE2022, VOL 2B, 2022,
  • [22] Inhaled insulin: A proof-of-concept study
    Cefalu, WT
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) : 795 - 795
  • [23] Nilotinib for treating MSA: A preclinical proof of concept study
    Guerin, P.
    Lopez-Cuina, M.
    Bezard, E.
    Meissner, W.
    Fernagut, P-O
    MOVEMENT DISORDERS, 2018, 33 : S433 - S433
  • [24] Nilotinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia
    Jarkowski, Anthony, III
    Sweeney, Richard P.
    PHARMACOTHERAPY, 2008, 28 (11): : 1374 - 1382
  • [25] Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib
    Tanaka, C.
    Yin, O. Q. P.
    Sethuraman, V.
    Smith, T.
    Wang, X.
    Grouss, K.
    Kantarjian, H.
    Giles, F.
    Ottmann, O. G.
    Galitz, L.
    Schran, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (02) : 197 - 203
  • [26] Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor
    Tian, Xianbin
    Zhang, Hefei
    Heimbach, Tycho
    He, Handan
    Buchbinder, Aby
    Aghoghovbia, Mary
    Hourcade-Potelleret, Florence
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (12): : 1533 - 1540
  • [27] Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
    Carracedo, Miguel
    Stenke, Leif
    Franco-Cereceda, Anders
    Back, Magnus
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 123 - 126
  • [28] A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
    Hansen, Timothy
    Little, Anthony J.
    Miller, Jeffrey J.
    Ioffreda, Michael D.
    JAMA DERMATOLOGY, 2013, 149 (03) : 330 - 332
  • [29] Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case
    Aslaner, A. K. Muzeyyen
    Ertop Dogan, Pelin
    Sahip, Birsen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 763 - 765
  • [30] Blockgraph Proof-of-Concept
    Cordova, David A. M.
    Velloso, Pedro B.
    Guerre, Alexandre
    Nguyen, Thi-Mai-Trang
    Pujolle, Guy
    Alagha, Khaldoun
    Dua, Guillaume
    PROCEEDINGS OF THE 2021 SIGCOMM 2021 POSTER AND DEMO SESSIONS, SIGCOMM 2021 DEMOS AND POSTERS, 2024, : 82 - 84
12345